OpenAlex
PricingAboutJobs
Log inGet started
Work

Determination of dabigatran, rivaroxaban and apixaban by ultra‐performance liquid chromatography – tandem mass spectrometry (UPLC‐MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants

HTML PDF

Year: 2014
Type: article
Source: Journal of Thrombosis and Haemostasis
DOI: 10.1111/jth.12702
Authors: E.M.H. Schmitz, K. Boonen, D.J.A. van den Heuvel, J.L.J. van Dongen, M.W.M. Schellings, J.M.A. Emmen, F. van der Graaf, L. Brunsveld, D. van de Kerkhof
Institutions: Catharina Ziekenhuis, Eindhoven University of Technology, Máxima Medisch Centrum
Language: English

Topic: Atrial Fibrillation Management and Outcomes
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: dabigatran, rivaroxaban, apixaban, direct oral anticoagulants, anticoagulation monitoring, coagulation tests, anti-factor Xa assay, anti-Xa assay, thrombin time, UPLC-MS/MS quantification, method validation, assay agreement, proficiency testing
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W1976542477
FWCI: 13.28
Cites: 32
Cited by: 186
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security